
Stoke Therapeutics Inc (STOK) recent activity suggests a positive outlook with the last week’s performance of -4.10%
On Friday, Stoke Therapeutics Inc (NASDAQ: STOK) was -1.47% drop from the session before settling in for the closing price of $9.50. A 52-week range